132 related articles for article (PubMed ID: 31258767)
1. Neuroblastoma by chance.
Tonini GP
J Cancer; 2019; 10(12):2601-2603. PubMed ID: 31258767
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition and chromosome instability in neuroblastoma.
Tonini GP; Capasso M
Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
[TBL] [Abstract][Full Text] [Related]
3. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
Tonini GP
BMC Cancer; 2017 Jan; 17(1):20. PubMed ID: 28056863
[TBL] [Abstract][Full Text] [Related]
4. Chromosome instability in neuroblastoma.
Fusco P; Esposito MR; Tonini GP
Oncol Lett; 2018 Dec; 16(6):6887-6894. PubMed ID: 30546420
[TBL] [Abstract][Full Text] [Related]
5. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
6. Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.
Masecchia S; Coco S; Barla A; Verri A; Tonini GP
BMC Med Genomics; 2015 Sep; 8():57. PubMed ID: 26358114
[TBL] [Abstract][Full Text] [Related]
7. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
8. Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domains.
Zanon C; Tonini GP
Mol Oncol; 2017 Nov; 11(11):1646-1658. PubMed ID: 28941026
[TBL] [Abstract][Full Text] [Related]
9. Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.
Abel F; Ejeskär K; Kogner P; Martinsson T
Br J Cancer; 1999 Dec; 81(8):1402-9. PubMed ID: 10604740
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma-A Neural Crest Derived Embryonal Malignancy.
Johnsen JI; Dyberg C; Wickström M
Front Mol Neurosci; 2019; 12():9. PubMed ID: 30760980
[TBL] [Abstract][Full Text] [Related]
11. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.
Caron H; van Sluis P; Buschman R; Pereira do Tanque R; Maes P; Beks L; de Kraker J; Voûte PA; Vergnaud G; Westerveld A; Slater R; Versteeg R
Hum Genet; 1996 Jun; 97(6):834-7. PubMed ID: 8641706
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
14. Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.
Meltzer SJ; O'Doherty SP; Frantz CN; Smolinski K; Yin J; Cantor AB; Liu J; Valentine M; Brodeur GM; Berg PE
Br J Cancer; 1996 Dec; 74(12):1855-61. PubMed ID: 8980382
[TBL] [Abstract][Full Text] [Related]
15. MEIS homeobox genes in neuroblastoma.
Geerts D; Revet I; Jorritsma G; Schilderink N; Versteeg R
Cancer Lett; 2005 Oct; 228(1-2):43-50. PubMed ID: 15919149
[TBL] [Abstract][Full Text] [Related]
16. Nervous system: Embryonal tumors: Neuroblastoma.
Pudela C; Balyasny S; Applebaum MA
Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
